Cytochrome P450 Oxidase (CYP2C9)
Cytochrome P450 (abbreviated CYP, P450, infrequently CYP450) is a very large and diverse
superfamily of hemoproteins found in bacteria,
archaea and eukaryotes.[1] They are so named because of their properties i.e. bound to membranes within a
cell (cyto) and contain a heme pigment (chrome and P) which absorbs light at a wavelength of 450 nm when exposed to carbon
monoxide[2]. Cytochromes P450 use a
plethora of both exogenous and endogenous compounds as substrates in enzymatic reactions. Usually they form part of
multicomponent electron transfer chains, called P450-containing systems. The
most common reaction catalysed by cytochrome P450 is a monooxygenase reaction, i.e. insertion of one atom of oxygen into an
organic substrate (RH) while the other oxygen atom is reduced to water:
RH + O2 + 2H+ + 2e– → ROH + H2O
CYP enzymes have been identified from all lineages of life, including mammals, birds, fish, insects, worms, sea squirts, sea urchins, plants, fungi, slime molds, bacteria and archaea. More
than 7700 distinct CYP sequences are known (as of September 2007; see the web site of the P450 Nomenclature Committee for
current counts).[3]
- The name P450 refers to the "pigment at 450 nm", so named for the characteristic Soret
peak formed by absorbance of light at wavelengths near 450 nm when the heme iron is reduced (with sodium dithionite) and complexed to carbon monoxide.
Nomenclature
Genes encoding CYP enzymes, and the enzymes themselves, are designated with the abbreviation
"CYP", followed by an Arabic numeral indicating the gene family, a capital letter
indicating the subfamily, and another numeral for the individual gene. The convention is to italicise the name when referring to the gene. For example, CYP2E1 is the gene that encodes the
enzyme CYP2E1 – one of the enzymes involved in paracetamol
(acetaminophen) metabolism. The "CYP" nomenclature is the officially preferred naming convention. However, some gene or enzyme
names for CYPs may differ from this nomenclature, denoting the catalytic activity and the name of the compound used as substrate.
Examples include CYP5, thromboxane A2 synthase, abbreviated to TXAS
(ThromboXane A2 Synthase), and CYP51, lanosterol 14-α-demethylase, abbreviated to LDM
according to its substrate (Lanosterol) and activity (DeMethylation). [1]
The current nomenclature guidelines suggest that members of new CYP families share >40% amino acid identity, while members
of subfamiles must share >55% amino acid identity. There is a Nomenclature Committee that keeps track of and assigns new names.
Mechanism
-
The active site of cytochrome P450 contains a heme iron center. The iron is tethered to the P450
protein via a thiolate ligand derived from a cysteine residue.
This cysteine and several flanking residues (RXCXG) are highly conserved in known CYPs[4]. Because of the vast variety of reactions catalyzed by CYPs, the activities and
properties of the many CYPs differ in many aspects. A general description of the P450 enzyme properties can be summarized as
follows:
- 1. The resting state of the protein is as oxidized Fe3+.
- 2. Binding of a substrate initiates electron transport and oxygen binding.
- 3. Electrons are supplied to the CYP by another protein, either cytochrome P450
reductase, ferredoxins, or cytochrome b5 to
reduce the heme iron.
- 4. Molecular oxygen is bound and split by the reduced heme iron.
- 5. An iron-bound oxidant, in some cases an iron(IV) oxo[citation needed], oxidizes the substrate to an alcohol or an epoxide, regenerating the resting state
of the CYP.
Because most CYPs require a protein partner to deliver one or more electrons to reduce the iron (and eventually molecular
oxygen), CYPs are properly speaking part of P450-containing systems of proteins.
Five general schemes are known:
P450s in bacteria
Bacterial cytochromes P450 are often soluble enzymes and are involved in critical metabolic processes. Three examples that
have contributed significantly to structural and mechanistic studies are listed here, but many different families exist.
- Cytochrome P450cam (CYP101) originally from Pseudomonas putida has been
used as a model for many cytochrome P450s and was the first cytochrome P450 three-dimensional protein structure solved by x-ray
crystallography. This enzyme is part of a camphor-hydroxylating catalytic cycle comprised of two electron transfer steps from
putidaredoxin, a 2Fe-2S cluster-containing protein cofactor.
- Cytochrome P450 eryF (CYP107A1) originally from the actinomycete bacterium Saccharopolyspora
erythraea is responsible for the biosynthesis of the antibiotic erythromycin by C6-hydroxylation of the macrolide 6-deoxyerythronolide B.
- Cytochrome P450 BM3 (CYP102A1) from the soil bacterium Bacillus
megaterium catalyzes the NADPH-dependent hydroxylation of several long-chain fatty acids at the ω–1 through ω–3
positions. Unlike almost every other known CYP (except CYP505A1, cytochrome P450 foxy), it constitutes a natural fusion protein
between the CYP domain and an electron donating cofactor. Thus, BM3 is potentially very useful in biotechnological
applications.[5][6]
P450s in plants
Plant cytochrome P450s are involved in a wide range of biosynthetic reactions, leading to various fatty acid conjugates, plant hormones, defensive compounds, or medically important drugs. Terpenoids, which represent the largest class of characterized natural plant compounds, are often substrates
for plant CYPs.
P450s in animals
Animal CYPs are primarily membrane-associated proteins, located either in the inner membrane
of mitochondria or in the endoplasmic
reticulum of cells. CYPs metabolise thousands of endogenous and exogenous compounds. Most CYPs can metabolize multiple
substrates, and many can catalyze multiple reactions, which accounts for their central importance in metabolizing the extremely
large number of endogenous and exogenous molecules. In the liver, these substrates include drugs
and toxic compounds as well as metabolic products such as bilirubin (a breakdown product of
hemoglobin). Cytochrome P450 enzymes are present in many other tissues of the body including the mucosa of the gastrointestinal tract, and play important
roles in hormone synthesis and breakdown (including estrogen
and testosterone synthesis and metabolism), cholesterol synthesis, and vitamin D metabolism. In most animals,
including humans, hepatic cytochromes P450 are the most widely
studied of the P450 enzymes.
The Human Genome Project has identified more than 63 human genes (57 full genes and 5 pseudogenes) coding for the various cytochrome P450
enzymes.[7]
Drug metabolism
In drug metabolism, cytochrome P450 is probably the most important element of oxidative metabolism (a part of Phase I
metabolism) in animals (metabolism in this context being the chemical modification or degradation of chemicals including drugs
and endogenous compounds). Many drugs may increase or decrease the activity of various CYP isozymes in a phenomenon known as
enzyme induction and inhibition. This is a major source of adverse
drug interactions, since changes in CYP enzyme activity may affect the metabolism and clearance of various drugs. For example, if one drug inhibits the CYP-mediated metabolism
of another drug, the second drug may accumulate within the body to toxic levels, possibly causing an overdose. Hence, these drug interactions may necessitate dosage adjustments or choosing drugs which do not
interact with the CYP system. In addition, naturally occurring compounds may cause a similar effect. For example,
bioactive compounds found in grapefruit
juice and some other fruit juices, including bergamottin, dihydroxybergamottin, and paradisin-A, have been found to inhibit
CYP3A4-mediated metabolism of certain medications, leading to
increased bioavailability and thus the strong possibility of overdosing.[8] Because of this risk,
avoiding grapefruit juice and fresh grapefruits entirely while on drugs is usually advised.
Other specific CYP functions in animals
A subset of cytochrome P450 enzymes play important roles in the synthesis of steroid
hormones by the adrenals, gonads, and peripheral
tissue:
- CYP11A1 (also known as P450scc or P450c11a1) in adrenal
mitochondria effects “the activity formerly known as 20,22-desmolase” (steroid
20α-hydroxylase, steroid 22-hydroxylase, cholesterol side chain scission).
- CYP11B1 (encoding the protein P450c11β) found in the inner mitochondrial membrane of adrenal cortex has
steroid 11β-hydroxylase, steroid 18-hydroxylase, and steroid 18-methyloxidase
activities.
- CYP11B2 (encoding the protein P450c11AS), found only in the mitochondria of the
adrenal zona glomerulosa, has steroid 11β-hydroxylase, steroid 18-hydroxylase, and
steroid 18-methyloxidase activities.
- CYP17A1, in endoplasmic reticulum of adrenal cortex has steroid 17α-hydroxylase and
17,20-lyase activities.
- CYP21A1 (P450c21) in adrenal cortex conducts 21-hydroxylase activity.
- CYP19A (P450arom, aromatase) in endoplasmic reticulum of gonads, brain, adipose tissue, and elsewhere catalyzes aromatization of
androgens to estrogens.
CYP Families in humans
Humans have 57 genes and more than 59 pseudogenes divided among 18 families of cytochrome
P450 genes and 43 subfamilies.[9] This is a summary of the
genes and of the proteins they encode. See the homepage of the Cytochrome P450 Nomenclature Committee for detailed
information.[7]
| Family |
Function |
Members |
Names |
| CYP1 |
drug and steroid (especially estrogen) metabolism |
3 subfamilies, 3 genes, 1 pseudogene |
CYP1A1, CYP1A2, CYP1B1 |
| CYP2 |
drug and steroid metabolism |
13 subfamilies, 16 genes, 16 pseudogenes |
CYP2A6, CYP2A7, CYP2A13,
CYP2B6, CYP2C8, CYP2C9,
CYP2C18, CYP2C19, CYP2D6,
CYP2E1, CYP2F1, CYP2J2,
CYP2R1, CYP2S1, CYP2U1,
CYP2W1 |
| CYP3 |
drug and steroid (including testosterone)
metabolism |
1 subfamily, 4 genes, 2 pseudogenes |
CYP3A4, CYP3A5, CYP3A7,
CYP3A43 |
| CYP4 |
arachidonic acid or fatty acid metabolism |
6 subfamilies, 11 genes, 10 pseudogenes |
CYP4A11, CYP4A22, CYP4B1,
CYP4F2, CYP4F3, CYP4F8,
CYP4F11, CYP4F12, CYP4F22,
CYP4V2, CYP4X1, CYP4Z1 |
| CYP5 |
thromboxane A2 synthase |
1 subfamily, 1 gene |
CYP5A1 |
| CYP7 |
bile acid biosynthesis 7-alpha hydroxylase of steroid nucleus |
2 subfamilies, 2 genes |
CYP7A1, CYP7B1 |
| CYP8 |
varied |
2 subfamilies, 2 genes |
CYP8A1 (prostacyclin synthase), CYP8B1 (bile acid biosynthesis) |
| CYP11 |
steroid biosynthesis |
2 subfamilies, 3 genes |
CYP11A1, CYP11B1, CYP11B2 |
| CYP17 |
steroid biosynthesis, 17-alpha hydroxylase |
1 subfamily, 1 gene |
CYP17A1 |
| CYP19 |
steroid biosynthesis: aromatase synthesizes
estrogen |
1 subfamily, 1 gene |
CYP19A1 |
| CYP20 |
unknown function |
1 subfamily, 1 gene |
CYP20A1 |
| CYP21 |
steroid biosynthesis |
2 subfamilies, 2 genes, 1 pseudogene |
CYP21A2 |
| CYP24 |
vitamin D degradation |
1 subfamily, 1 gene |
CYP24A1 |
| CYP26 |
retinoic acid hydroxylase |
3 subfamilies, 3 genes |
CYP26A1, CYP26B1, CYP26C1 |
| CYP27 |
varied |
3 subfamilies, 3 genes |
CYP27A1 (bile acid biosynthesis), CYP27B1 (vitamin D3 1-alpha hydroxylase, activates vitamin D3), CYP27C1 (unknown function) |
| CYP39 |
7-alpha hydroxylation of 24-hydroxycholesterol |
1 subfamily, 1 gene |
CYP39A1 |
| CYP46 |
cholesterol 24-hydroxylase |
1 subfamily, 1 gene |
CYP46A1 |
| CYP51 |
cholesterol biosynthesis |
1 subfamily, 1 gene, 3 pseudogenes |
CYP51A1 (lanosterol 14-alpha demethylase) |
References
- ^ International Union of Pure and Applied Chemistry. "cytochrome P450". Compendium of Chemical Terminology Internet edition. Danielson P (2002). "The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans".
Curr Drug Metab 3 (6): 561-97. PMID 12369887.
- ^ Lynch T, Price A
(2007). "The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects". American family
physician 76 (3): 391–6. PMID 17708140.
- ^ http://drnelson.utmem.edu/CytochromeP450.html
- ^ DR Nelson
- ^ Narhi L, Fulco A (1986). "Characterization of a
catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus
megaterium". J Biol Chem 261 (16): 7160-9. PMID 3086309.
- ^ Girvan H, Waltham T, Neeli R, Collins H,
McLean K, Scrutton N, Leys D, Munro A (2006). "Flavocytochrome P450 BM3 and the origin of CYP102 fusion species". Biochem Soc
Trans 34 (Pt 6): 1173-7. PMID 17073779.
- ^ a b http://drnelson.utmem.edu/human.P450.table.html
- ^ Bailey DG, Dresser GK (2004). "Interactions
between grapefruit juice and cardiovascular drugs". Am J Cardiovasc Drug 4 (5): 281-297. PMID
15449971.
- ^ Nelson D (2003). Cytochrome P450s in humans. Retrieved May 9, 2005.
External links
|
Cytochromes, oxygenases:
cytochrome P450 (EC 1.14) |
| CYP1 |
A1, A2, B1 |
| CYP2 |
A6,
A7, A13, B6, C8, C9, C18, C19, D6, E1, F1,
J2, R1, S1, U1, W1 |
| CYP3 |
A4, A5, A7, A43 |
| CYP4 |
A11,
A22, B1, F2, F3, F8, F11, F12, F22, V2, X1, Z1 |
| CYP5-20 |
CYP5 (A1) - CYP7
(A1, B1) - CYP8 (A1, B1) - CYP11 (A1, B1, B2) - CYP17 (A1) - CYP19 (A1) - CYP20 (A1) |
| CYP21-51 |
CYP21 (A2) - CYP24 (A1) - CYP26 (A1, B1, C1) - CYP27 (A1, B1, C1) -
CYP39 (A1) - CYP46 (A1) - CYP51
(A1) |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)